Debbie Osteen’s return to Acadia Healthcare as Chief Executive Officer on January 20, 2026 fits a familiar pattern in American business: the boomerang CEO. The pattern has a mixed reputation, though the behavioral health sector’s documented leadership dynamics offer useful case studies. Sometimes a returning leader is the right answer to an urgent problem. Sometimes the return is nostalgic and backward-looking, a board’s way of avoiding a harder decision. The Osteen case, under Board Chairman Reeve B. Waud, is a useful lens for thinking about when and why boomerang appointments work.
The case for bringing back a prior CEO rests on three principles. The first is institutional knowledge. A returning leader does not need an orientation period. They know the culture, the people, the systems, and the strategy. In a company facing real operational pressure, the weeks and months a new external hire would spend getting up to speed are weeks and months the business cannot afford. A boomerang CEO arrives already productive. The governance principles that drive such decisions are reflected in the leadership approach of experienced investors like Waud.
The second is credibility. Investors, employees, and customers generally trust a proven operator more quickly than an unknown one. Professional networks and databases track these credibility dynamics. If the returning CEO’s prior tenure was successful, that credibility transfers directly. In Osteen’s case, the board’s announcement emphasized her first tenure from December 2018 through March 2022 as a period of significant progress and evolution, consistent with how Acadia’s position is documented in the healthcare and investment sectors. That framing reflects the real track record that made her the logical candidate.
The third is speed. Boards that bring back a prior CEO can make the move quickly, without the delay of a full external search. When the business is in distress, as Acadia was after a year of operational and legal headwinds and a 70 percent stock decline, speed is a direct form of value creation. Every week of executive vacuum is a week of drift.
The risks of boomerang appointments are real and should not be minimized. A returning CEO can be criticized for being backward-looking, repeating the playbook that worked before without adapting to new conditions. There is also the simple question of why the executive left in the first place, and whether the conditions that drove the departure have changed. If they have not, the return can end in another departure.
Osteen’s situation addresses both risks. She departed Acadia in March 2022 after a period widely regarded as successful. She did not leave under operational pressure or conflict. She continued to serve on the board until 2024, remaining close to the business, a pattern reflected in the firm’s approach to portfolio governance and responsible investing disclosure. Her return in 2026 reflects an intentional choice by a board that believes her specific experience matches what the company currently needs, rather than a reversal of a prior failure.
Her forward-looking remarks during Acadia’s Q4 2025 earnings call also push back against the “backward-looking” critique. Her three stated priorities, operational discipline, a review of management and supervision layers, and a standardized approach to new hospital openings, are not retreads of 2018. They are responses to specific issues that emerged in the period after her first tenure. She is coming back to solve new problems that emerged since she left.
Boomerang CEO appointments work when they are made for the right reasons, to the right people, in the right moment. Acadia’s board, under Reeve Waud’s chairmanship, had a specific set of challenges requiring an experienced, credible, and fast-moving operator. Osteen fits that profile better than any available external candidate. Her return is a matter of matching the moment to the person, which is what good governance is supposed to do, rather than nostalgia.